Gujarat Kidney And Super Speciality (NSE:GKSL) ROCE %: 8.16% (As of Mar. 2026)


NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹129.23
! 5 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality ROCE %?

Gujarat Kidney And Super Speciality NSE:GKSL +0.83% 18 ROCE % is 8.16% as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gujarat Kidney And Super Speciality's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.16%.

Gujarat Kidney And Super Speciality  (NSE:GKSL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gujarat Kidney And Super Speciality ROCE % Related Terms

Gujarat Kidney And Super Speciality ROCE % Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality ROCE % Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROCE %
28.83 36.02 25.40 14.08

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial 32.01 12.08 76.80 33.73 8.16
NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality ROCE % Calculation

Gujarat Kidney And Super Speciality's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=231.129/( ( (912.94 - 327.738) + (2976.4 - 278.15) )/ 2 )
=231.129/( (585.202+2698.25)/ 2 )
=231.129/1641.726
=14.08 %

Gujarat Kidney And Super Speciality's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=220.152/( ( (0 - 0) + (2976.4 - 278.15) )/ 1 )
=220.152/( ( 0 + 2698.25 )/ 1 )
=220.152/2698.25
=8.16 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.16% mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a ROCE % of 8.16% as of Mar. 2026.
Is Gujarat Kidney And Super Speciality's ROCE % too high?
Gujarat Kidney And Super Speciality's current ROCE % is 8.16%. The Healthcare Providers & Services industry median ROCE % is 6.43. Gujarat Kidney And Super Speciality's value of 8.16% is 26.9% above this industry median. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's ROCE % compare to HCA and THC?
Gujarat Kidney And Super Speciality's ROCE % of 8.16% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. Gujarat Kidney And Super Speciality's value of 8.16% is 26.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current ROCE % of 8.16% is 26.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current ROCE % is 8.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current ROCE % of 8.16%. The current ROCE % is 8.16% and 26.9% above the Healthcare Providers & Services industry median of 6.43. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current ROCE % is 8.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹129.23
Price